CASI Pharmaceuticals (NYSE: CASI) — Perfil da empresa, notícias e dados financeiros

CASI Pharmaceuticals (NASDAQ:CASI) is focused on developing and commercializing innovative therapeutics and pharmaceutical products, primarily for the treatment of cancer and other life-threatening diseases. The company is traded on the NASDAQ stock exchange under the ticker symbol CASI. With a commitment to improving patient outcomes, CASI Pharmaceuticals has a diverse portfolio of products in various stages of development, from research and pre-clinical trials to late-stage clinical trials. Their operations encompass a wide range of activities, including drug discovery, development, manufacturing, and commercialization, with the objective to bring new and effective treatments to market. The company collaborates with partners globally to leverage cutting-edge science in pursuit of breakthrough treatments.